Options Recap, 4 Fresh Ideas & More

Thursday’s Options Review: 

We’re ready to wrap up another trading week today, and it was a heck of solid one for us on the options front. We were bearish on most of our highlighted ideas for the day, and the markets took a serious dive in the second half of the session, which facilitated some kind gains. However, our one bullish target bucked the overall trend and delivered some notable intraday moves as well, so all in all it was a pretty good outing.

The winning targets that we were focusing our attention upon were the SIG Weekly $65-67 Calls, the BILI Weekly $27.50-26.50 Puts, and the NIO Weekly $20.50-19.50 Puts. The potential gains they yielded for the session were very respectable, and went as follows:

SIG Weekly $65-67 Calls
$65:
 2.69-5.00 (+86%)
$66: 1.85-4.10 (+122%)
$67: 1.35-3.30 (+144%)
_____

BILI Weekly $27.50-26.50 Puts
$27.50:
 1.24-2.65 (+114%)
$27: .80-2.18 (+173%)
$26.50: .60-1.88 (+213%)
_____

NIO Weekly $20.50-19.50 Puts
$20.50:
 1.06-1.80 (+70%)
$20: .70-1.36 (+94%)
$19: .45-.95 (+111%)


Fresh Options Ideas:
BABA Weekly $110-113 Calls
DOCU Weekly $68-65 Puts
SPY 06/10 $400-398 Puts
SFIX Weekly $7-6.50 Puts


Extended Watchlist:
AHFD, ALMTF, MWWC, EBML, ITNS, TCRT, PALT, BRQS, NISN, RGS, BIMI

More Sweeping Options Success, Fresh Ideas

A Second Consecutive Clean Options Sweep:

We crushed it on options ideas in Friday morning’s premarket report, setting our readers up with three earnings related trading possibilities, all of which produced big intraday gains. The markets slid all the way until shortly after lunchtime, and then clawed their way back, running into the close, which allowed for great movement in both our bullish and bearish ideas. It was the second straight day where literally everything we highlighted went bananas.

We were tracking the FL Weekly $29-31 Calls, the PANW Weekly $475-487.50 Calls, and the DE Weekly $360-350 Puts, and each and every contract set contained within those ranges recorded large runs, and yielded the chance at the following excellent gain opportunities:

FL Weekly $29-31 Calls
$29:
 1.80-2.80 (+56%)
$30: .87-1.85 (+113%)
$31: .38-.99 (+161%)
_____

PANW Weekly $475-487.50 Calls
$475: .25.-3.67 (+1368%)
$477.50: .20-2.00 (+900%)
$480: 5.98-16.00 (+168%)
$482.50: 6.06-11.00 (+82%)
$485: 4.00-11.89 (+197%)
$487.50: 3.77-10.55 (+180%)
_____

DE Weekly $360-350 Puts

$360: 15.50-51.00 (+229%)
$355: 14.00-47.04 (+236%)
$350: 12.35-45.42 (+268%)


Fresh Options Ideas:
SPY 05/23 $391-393 Calls*
COIN 06/10 $70 Calls

*Trading options on their day of expiration can be risky. Please don’t try it unless you are well-versed in options trading. 


Siga Technologies, Inc. SIGA – Update:

It’s always a good idea to copy our daily extended watchlists into your favorite tracking site/software and monitor their activity along with us. Many times they will contain hidden OTC gems like SIGA, which just received FDA approval for intravenous (IV) formulation of its TPOXX® monkeypox treatment. It was even mentioned by name in a recent budget request from the Biden administration for treatments against the rising health threat.

SIGA appeared in Thursday morning’s extended watchlist and saw a low of 8.00 that day. This morning in early trading the stock is up as much as 119% to a premarket high of 17.50. We will continue tracking its movements as the FDA news continues to filter through the investment community.


Extended Watchlist:
PBI, CMRX, GOVX, CBIO, VMW, PRCX, THER, RDGL, HIRU, ITNS, URYL

BMSN, KERX & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN

BMSN has been a main point of focus for us this year. We first began paying close attention to BMSN towards the end of 2012 when it was trading as low as .0003. Yesterday, the stock had another rockstar performance, reaching new highs and cracking through another major resistance point at .0035 (200DMA).

After the initial surge we saw from .0003-.0024, we wanted to see support hold off of .001. Now that we have hit new highs, we are raising the bar and looking for new support to hold  at .0035, or below that, the 20DMA of .0021. If we can see these areas hold as support, we are going to remain bullish on BMSN.

Over the span of our coverage on BMSN, we have been afforded the opportunity at an accumulation of up to 1400% in possible gains from .0003 to yesterday’s high of .0045

Most Recent News:

SAN DIEGO, CA, Jan 24, 2013 (MARKETWIRE via COMTEX) — Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific Group Inc. (PINKSHEETS: BMSN), announced today publication in a peer reviewed medical journal the scientific basis for its HemaXellerate(TM) bone marrow failure product. The manuscript is available at http://www.translational-medicine.com/content/pdf/1479-5876-10-231.pdf. The publication is an overview of the Investigational New Drug (IND) application that the company plans to file for initiating clinical trials.

__

Keryx Biopharmaceuticals, Inc. KERX

KERX earned us a spot in the Penny Stock Rumble on Tuesday, racking up another solid day of gains, and hitting a high of 8.79. That brings our total possible profits to a very respectable 154%

We are going to be monitoring the activity on KERX following yesterday’s announcement regarding the comnpany’s planned $55M public offering.

Yesterday’s News:

NEW YORK, Jan. 29, 2013 /PRNewswire via COMTEX/ — Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced that it has commenced a $55 million underwritten public offering of shares of its common stock. In connection with this offering, Keryx expects to grant to the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. J.P. Morgan is acting as the sole book-running manager in the offering.

__

Extended Watchlist:
SCXN, ITNS, MYRY, SWVI, ONCI, ENTB